Patrick D Spangler's Net Worth

$1.16 Million

Estimate Recalculated May 6, 2024 08:37PM EST

Who is Patrick D Spangler?

Patrick D Spangler has an estimated net worth of $1.16 Million. This is based on reported shares across multiple companies, which include OptimizeRx Corp, ev3 Inc., UROLOGIX INC, and EPOCRATES INC.

SEC CIK

Patrick D Spangler's CIK is 0001296525

Past Insider Trading and Trends

2020 was Patrick D Spangler's most active year for acquiring shares with 5 total transactions. Patrick D Spangler's most active month to acquire stocks was the month of October. 2007 was Patrick D Spangler's most active year for disposing of shares, totalling 8 transactions. Patrick D Spangler's most active month to dispose stocks was the month of October. 2018 saw Patrick D Spangler paying a total of $945.25 for 4,263 shares, this is the most they've acquired in one year. In 2021 Patrick D Spangler cashed out on 6,252 shares for a total of $527,543.76, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OptimizeRx Corp (OPRX) Snapshot price: $14.87

SVP Product & Strategy

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+26.52%
4.64K
—
—
22.12K
Jun 7
Form 4
+3.90%
657
—
—
17.48K
Mar 31
Form 4
+2.49%
409
—
—
16.83K
Dec 30
Form 4
+2.08%
334
—
—
16.42K
Sep 29
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Dec 30
Form 4
-27.99%
-6.25K
$84.38
-$527,543.76
16.08K
Scheduled
Nov 11
Form 4
—
0
—
—
0
Sep 29
Form 4
+1.86%
407
—
—
22.34K
Jun 30
Form 4
+2.52%
539
—
—
21.93K
Mar 31
Form 4
+10.23%
1.99K
—
—
21.39K
Sep 30 - Dec 31
Form 4
+11.09%
1.94K
—
—
19.4K
Jun 30
Form 4
+18.96%
2.78K
—
—
17.47K
Mar 30
Form 4
+16.54%
2.08K
—
—
14.68K
Jan 3
Form 4
+19.82%
2.08K
—
—
12.6K
Sep 30
Form 4
+48.89%
2.08K
—
—
6.35K
Mar 29
Form 4
+95.64%
2.08K
—
—
4.26K
Oct 8
Form 4
+2,193.68%
2.08K
—
—
2.18K
Jun 29
Form 4
∞
95
$9.95
$945.25
95
Jun 27
Form 3
—
0
—
—
0
No matching records found

ev3 Inc. No price found

Sr. VP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.84%
-6.57K
$5.59
-$36,682.22
60.17K
Scheduled
Nov 15 - Nov 17
Form 4
+81.67%
30K
—
—
66.73K
Apr 30
Form 4
-4.29%
-1.65K
$15.05
-$24,763.86
36.73K
Scheduled
Nov 16
Form 4
+133.34%
21.93K
—
—
38.38K
Oct 4
Form 4
∞
16.45K
—
—
16.45K
Jan 22
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

UROLOGIX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+41.40%
45.45K
—
—
155.26K
Nov 6
Form 4
+83.61%
50K
—
—
109.8K
Nov 7
Form 4
+79.66%
26.52K
—
—
59.8K
Nov 16
Form 4
+118.35%
18.04K
—
—
33.29K
Nov 8
Form 4
∞
15.24K
—
—
15.24K
Nov 9
Form 3
—
0
—
—
0
No matching records found

EPOCRATES INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 20
Form 3
—
0
—
—
0
No matching records found